# AI Drug Discovery
Latest news and articles about AI Drug Discovery
Total: 3 articles found
AI-Driven Drug Discovery Reaches $2.5 Billion Milestone as Insilico and SK Biopharmaceuticals Ink Mega-Deal
Insilico Medicine and SK Biopharmaceuticals have entered into a $2.5 billion strategic partnership to develop AI-driven treatments for neuro-immune diseases. The deal highlights the pharmaceutical industry's aggressive pivot toward generative AI to streamline and accelerate the discovery of complex drug candidates.
The AI Pipeline Factory: China’s HBM and BioMap Forge a New Frontier in Tech-Bio
HBM Holdings and BioMap have launched MegaStream TechBio, a joint venture dedicated to designing complex macromolecules using generative AI foundation models. The initiative seeks to transition the industry from traditional trial-and-error methods to a predictive 'AI Pipeline Factory' model that integrates high-throughput physical validation with computational design.
From Bench to Bedside: Isomorphic Labs Targets $2 Billion to Scale AI-Driven Drug Discovery
Isomorphic Labs, a spin-off of Google's DeepMind, is in advanced talks to raise over $2 billion in a funding round led by Thrive Capital. The company aims to leverage its proprietary AI models to revolutionize drug discovery, marking a significant escalation in Big Tech’s expansion into the pharmaceutical sector.